3-(2-(哌啶-1-基)乙氧基)苯胺 | 373824-23-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 3-(2-(哌啶-1-基)乙氧基)苯胺
• 英文名称: 3-(2-piperidin-1-yl-ethoxy)-phenylamine
• 英文别名: 1-(2-(3-aminophenoxy)ethyl)piperidine；3-(2-(Piperidin-1-yl)ethoxy)aniline；3-(2-piperidin-1-ylethoxy)aniline
• CAS: 373824-23-8
• 化学式: C₁₃H₂₀N₂O
• mdl: MFCD09035171
• 分子量: 220.315
• InChiKey: FLRCQMIOFFBPAU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.538
• 拓扑面积：
  38.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(2-(哌啶-1-基)乙氧基)苯胺 在 titanium(IV) isopropylate 、 lithium aluminium tetrahydride 、 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 、 sodium cyanoborohydride 、 N,N-二异丙基乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 为溶剂， 生成 N-[(1R,3S)-3-(3-Chloro-benzylamino)-cyclohexylmethyl]-4-fluoro-N-[3-(2-piperidin-1-yl-ethoxy)-phenyl]-benzamide
  参考文献：
  名称：

  Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists

  摘要：

  A series of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives were synthesized as motilin receptor antagonists. Starting from known motilin antagonists, 1a and 1b, the cyclopentene scaffold was replaced and the four recognition elements optimized to arrive at a potent novel series. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.04.017
• 作为产物：
  描述：

  1-[2-(3-硝基-苯氧基)-乙基]-哌啶 在 palladium 10% on activated carbon 氢气 作用下， 以 乙醇 为溶剂， 20.0 ℃ 、344.75 kPa 条件下， 反应 0.5h， 以100%的产率得到3-(2-(哌啶-1-基)乙氧基)苯胺
  参考文献：
  名称：

  WO2007/30680

  摘要：

  公开号：

文献信息

• Metasubstituted thiazolidinones, their manufacture and use as a drug
  申请人：Schulze Klaus Volker

  公开号：US20070015759A1

  公开（公告）日：2007-01-18

  This invention involves thiazolidinone of general formula (I) and its creation and use as inhibitors of polo like kinase (PLK) for the treatment of various diseases.

  这项发明涉及一般式(I)的噻唑烷酮及其作为极化样激酶（PLK）抑制剂的创造和用途，用于治疗各种疾病。
• Novel substituted diamine derivatives useful as motilin antagonists
  申请人：——

  公开号：US20020013352A1

  公开（公告）日：2002-01-31

  The present invention relates to novel substituted diamine derivatives for the formula 1 wherein R 1 , R 2 , R 3 , R 4 , X 1 , X 2 , X 3 , X 4 , A, Y and n are as described in the specification, pharmaceutical compositions containing them and intermediates used in their manufacture. More particularly, the compounds of the invention are motilin receptor antagonists useful for the treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome.

  本发明涉及一种新型的取代二胺衍生物，其化学式为1，其中R1、R2、R3、R4、X1、X2、X3、X4、A、Y和n如说明书中所述，包含它们的药物组合物以及用于它们制造的中间体。更具体地说，本发明的化合物是莫替林受体拮抗剂，可用于治疗相关疾病和疾病，如胃食管反流疾病、导致肥胖的进食障碍和肠易激综合征。
• Pyrazoles as tgf inhibitors
  申请人：——

  公开号：US20040097502A1

  公开（公告）日：2004-05-20

  Therapeutically active pyrazole derivatives of formula (I) wherein R 1 -R 3 are as defined in the specification, processes for the preparation thereof, the use thereof in therapy, particularly in the treatment of prophylaxis of disorders characterised by overexpression of transforming growth factor &bgr; (TGF-&bgr;), and pharmaceutical compositions for use in such therapy. 1

  公式（I）中的治疗活性吡唑衍生物，其中R1-R3如规范中所定义，其制备过程，其在治疗中的使用，特别是在治疗预防表现为转化生长因子&bgr;（TGF-&bgr;）过度表达的疾病方面的使用，以及用于此类治疗的制药组合物。
• Novel substituted diamine derivatives useful as motlin antagonists
  申请人：——

  公开号：US20030203906A1

  公开（公告）日：2003-10-30

  The present invention relates to novel substituted diamine derivatives for the formula 1 wherein R 1 , R 2 , R 3 , R 4 , X 1 , X 2 , X 3 , X 4 , A, Y and n are as described in the specification, pharmaceutical compositions containing them and intermediates used in their manufacture. More particularly, the compounds of the invention are motilin receptor antagonists useful for the treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome.

  本发明涉及一种新的取代二胺衍生物，其化学式为1，其中R1、R2、R3、R4、X1、X2、X3、X4、A、Y和n如规范中所述，以及含有它们的制药组合物和用于制造它们的中间体。更具体地说，本发明的化合物是胃动素受体拮抗剂，可用于治疗相关疾病和疾病，例如胃食管反流病、导致肥胖的进食障碍和肠易激综合征。
• NOVEL SUBSTITUTED DIAMINE DERIVATIVES USEFUL AS MOTILIN AGONISTS
  申请人：Johnson G. Sigmond

  公开号：US20070054888A1

  公开（公告）日：2007-03-08

  The present invention relates to novel substituted diamine derivatives for the formula wherein R 1 , R 2 , R 3 , R 4 , X 1 , X 2 , X 3 , X 4 , A, Y and n are as described in the specification, pharmaceutical compositions containing them and intermediates used in their manufacture. More particularly, the compounds of the invention are motilin receptor antagonists useful for the treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome.

  本发明涉及一种新的取代二胺衍生物，其化学式为R1，R2，R3，R4，X1，X2，X3，X4，A，Y和n如规范中所述，包含它们的制药组合物以及用于其制造的中间体。更具体地说，本发明的化合物是莫蒂林受体拮抗剂，可用于治疗相关疾病和疾病，如胃食管反流疾病，导致肥胖的进食障碍和肠易激综合征。